Process for making chloro-substituted nucleoside phosphoramidate compounds
View Patent ↗The present invention is directed to a process for making Chloro-Substituted Nucleoside Phosphoramidate Compounds of formula (I): which are useful for the treatment and prophylaxis of HCV infection. The present invention is also directed to compounds that are useful as synthetic intermediates for making the compounds of formula (I).
1. A compound having the formula:
X is selected from C 1 -C 6 alkylene, C 6 -C 10 arylene, C 4 -C 10 cycloalkylene, 5 or 6-membered monocyclic heteroarylene and 9 or 10-membered bicyclic heteroarylene, wherein said C 6 -C 10 arylene group, said C 4 -C 10 cycloalkylene group, said 5 or 6-membered monocyclic heteroarylene group and said 9 or 10-membered bicyclic heteroarylene group can be optionally substituted with one or more R 5 groups;
each occurrence of R 5 is independently selected from —C 1 -C 6 alkyl, halo, —OR 6 , —C(O)R 6 , —CO 2 R 6 , —SR 6 , —C 1 -C 6 hydroxyalkyl, —C 1 -C 6 haloalkyl, —N(R 6 ) 2 , —S(O)R 6 , —S(O) 2 R 6 , —CN and —NO 2 ;
each occurrence of R 6 is independently selected from H, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 hydroxyalkyl, —(C 1 -C 3 alkylene) m -(C 3 -C 7 cycloalkyl), —(C 1 -C 3 alkylene) m -(C 6 -C 10 aryl), —(C 1 -C 3 alkylene) m -(4 to 7-membered heterocycloalkyl), —(C 1 -C 3 alkylene) m -(5- or 6-membered monocyclic heteroaryl) and —(C 1 -C 3 alkylene) m -(9- or 10-membered bicyclic heteroaryl);
each occurrence of R 7 is independently selected from H, C 1 -C 6 alkyl, phenyl, C 3 -C 7 cycloalkyl, 4 to 7-membered monocyclic heterocycloalkyl and 5- or 6-membered monocyclic heteroaryl;
each occurrence of R 8 is independently selected from H, C 1 -C 6 alkyl, phenyl, C 3 -C 7 cycloalkyl, 4 to 7-membered monocyclic heterocycloalkyl and 5- or 6-membered monocyclic heteroaryl;
each occurrence of m is independently 0 or 1;
p is 2, 3, 4 or 5; and
q is 2, 3, 4 or 5.
2. The compound of claim 1 , having the structure: